Cardiovascular Systems Recalls Wirion Embolic Protection System

Cardiovascular Systems Inc CSII has commenced a voluntary recall of its WIRION Embolic Protection Systems (WIRION).

  • The unused WRN-D6 models of the WIRION device are being recalled due to receiving complaints regarding filter breakage at the time of retrieval.
  • The Company stated that the filter breakage might cause device embolism as well as additional intervention.
  • All affected healthcare facilities were informed to stop using and return the unused WIRION devices to the Company.
  • CSI has also notified the FDA regarding the voluntary recall.
  • The Company has received nine filter breakage complaints so far and plans to recall all the devices currently in customer inventory.
  • Between 22 March and 15 November, approximately 697 devices were distributed in the US.
  • WIRION is a rapid exchange, pre-loaded filter used as an embolic protection system for removing embolic material (thrombus/debris) while performing atherectomy in calcified lesions of the lower extremities.
  • In March, CSI acquired a portfolio of peripheral support catheters from WavePoint Medical.
  • These catheters are used during peripheral vascular intervention (PVI) procedures for guidewire support to aid in lesion crossing and for guidewire exchanges.
  • CSI expects to introduce the acquired catheters as its new ViperCross line in the first half of its fiscal year, ending on 30 June 2022.
  • Price Action: CSII shares closed at $23.72 on Wednesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsHealth CareSmall CapFDAGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!